An Orally Administered Nonpathogenic Attenuated Vaccine Virus Can Be Used to Control SARS-CoV-2 Infection: A Complementary Plan B to COVID-19 Vaccination

Background Coronavirus disease 2019 (COVID-19) vaccination has substantially altered the course of the pandemic, saving tens of millions of lives globally. The problem is that despite such spectacular results, vaccination alone will not be able to control the COVID-19 pandemic because of the rapid e...

Descripción completa

Detalles Bibliográficos
Autores principales: Bakacs, Tibor, Sandig, Volker, Kovesdi, Imre
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2022
Materias:
Allergy/Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9511982/
https://www.ncbi.nlm.nih.gov/pubmed/36176842
http://dx.doi.org/10.7759/cureus.28467

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9511982/
https://www.ncbi.nlm.nih.gov/pubmed/36176842
http://dx.doi.org/10.7759/cureus.28467

Ejemplares similares